Skip to content
healthcare.dev

Orphenadrine Citrate

NDC 66267-158, Orphenadrine Citrate, tablet, extended release, from NuCare Pharmaceuticals, Inc..

Product NDC
66267-158
Status
Listed
Labeler
NuCare Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66267-158 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORPHENADRINE CITRATE100 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
66267-158-206626701582020 TABLET, EXTENDED RELEASE in 1 BOTTLE (66267-158-20)
66267-158-306626701583030 TABLET, EXTENDED RELEASE in 1 BOTTLE (66267-158-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3eb1b1cc-ed7a-6f0f-e054-00144ff88e88

Use it

Look up 66267-158 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66267-158 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66267-158. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.